Aroa Biosurgery hopes for sales boost after study finds high healing rates

Aroa Biosurgery hopes for sales boost after study finds high healing rates
Aroa founder Brian Ward says the largest study to date of its tissue repair products bodes well for the firm. (Image: Aroa Biosurgery)
Rebecca Stevenson
Aroa Biosurgery founder Brian Ward says a new large study proving the efficacy and cost saving of its tissue repair products should help to convince conservative surgeons to use them. In late December Australian Securities Exchange (ASX) listed Aroa announced a peer-reviewed study of 120 inpatients for two of its treatments, Myriad Matrix and Myriad Morcells, in lower limb reconstructions. The study, which was published in a plastic and reconstructive surgery journal in December, found one application of Myriad achieved tissue coverag...

More Markets

Sharemarket closes marginally higher
Markets

Sharemarket closes marginally higher

The S&P/NZX 50 Index had a flat day, closing up 0.01%.

Dairy prices fall 1.4% at first 2025 auction
Primary Sector

Dairy prices fall 1.4% at first 2025 auction

The average price fell 1.4% to US$4029 a metric tonne.

Riley Kennedy 08 Jan 2025
Best of BusinessDesk: Image was everything for Du Val founders
Property

Maria Slade: Best of BusinessDesk: Image was everything for Du Val founders

Nothing enraged the Clarkes more than a hint they weren't wealthy high-flyers.

Maria Slade 08 Jan 2025
NZX dips despite US tech rally
Markets

NZX dips despite US tech rally

The S&P/NZX 50 Index closed at 13,042.06, down 30.87 points or 0.24%.

Graham Skellern 07 Jan 2025